Verition Fund Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-99,475
Closed -$21.6M 2350
2021
Q1
$21.6M Buy
+99,475
New +$18.7M 0.24% 55
2020
Q3
Sell
-8,317
Closed -$1.02M 1480
2020
Q2
$1.02M Buy
+8,317
New +$944K 0.03% 407
2020
Q1
Sell
-21,549
Closed -$2.25M 1185
2019
Q4
$2.25M Buy
21,549
+6,229
+41% +$698K 0.04% 251
2019
Q3
$1.76M Sell
15,320
-215
-1% -$32.6K 0.05% 277
2019
Q2
$2.68M Buy
+15,535
New +$2.69M 0.08% 183
2018
Q3
Sell
-2,309
Closed -$322K 1505
2018
Q2
$322K Buy
+2,309
New +$328K 0.02% 829

Other funds holding GWPH

Verition Fund Management's GWPH Position: Q2 2021 in Review

Verition Fund Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 99,475 shares — an estimated $21.6M sold.

Verition Fund Management first reported a position in GWPH in Q2 2018 and held it in 6 quarters. The position peaked at $21.6M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Verition Fund Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Verition Fund Management sold 99,475 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $21.6M.
  • Verition Fund Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 6 quarters.
  • Verition Fund Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $21.6M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Verition Fund Management's 13F filing for Q2 2021, filed 16 Aug 2021.